Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2012.443 | THE USE OF PILLCAM ESOPHAGUS IN TRIAGING PATIENTS PRESENTED WITH UPPER GASTROINTESTINAL BLEEDING | Prof. SUNG Joseph |
| 2012.371 | Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma: A Multicenter, Randomized, Controlled Trial | Prof. Sung Joseph |
| 2008.514 | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Ulcerative Colitis | Prof Sung Joseph |
| 2009.476 | Early Clinical Experience of the Safety and Efficacy of TC325 in Achieving Acute Hemostasis in Patients with Acute Peptic Ulcer Bleeding | Prof. Sung Joseph |
| 2011.150 | Clinical Evaluation of Hemospray: Hemostasis of Active GI Luminal Tract Bleeding (HALT) | Prof. Sung Joseph |
| 2008.507 | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab MLN0002 in Patients with Moderate to Severe Crohn | Prof Sung Joseph |
| 2008.508 | A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab MLN0002 in Patients with Ulcerative Colitis and Crohn | Prof Sung Joseph |
| 2011.503 | Validation of Asia-Pacific Colorectal Screening Score (APCS score) | Prof. SUNG Joseph Jao Yiu |
| 2017.055 | A retrospective analysis - would Baylor Bleeding Score be able to identify the patients who are at high risk of rebleeding? | Prof. SUNG Joseph Jao Yiu |
| 2020.219 | The diagnostic performance of fecal immunochemical test for detecting colorectal neoplasm in 40 to 49 year-old adults: retrospective review of medical records | Prof. SUNG Joseph Jao Yiu |
| 2018.234 | A multi-centered study: New technologies and plans for colorectal cancer screening |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2019.504 | Treatment of DM/Pre-DM in obese patients and its effects on microbiome, colonic adenoma and NAFLD | Prof. SUNG Joseph Jao Yiu |
| 2018.535 | Non-warfarin Oral AntiCoagulant resumption after Gastrointestinal bleeding in Atrial fibrillation Patients (NOAC-GAP) - a randomised controlled study |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2019.394 | Inflammatory bowel disease and risk prediction for acute severe colitis |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2009.106 | A Follow-up Study to Evaluate the Long-term Post Treatment Effects of Peginterferon Alfa-2a (PEG-IFN) in Patients with HBeAg Positive Chronic Hepatitis B from the Original Study WV19432 (NEPTUNE) | Prof Sung Joseph Jao-Yiu |
| 2009.404 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Prof. SUNG Joseph JY |
| 2008.143 | Functional Significance and Potential Clinical Application of a Novel Putative Tumor Suppressor (zinc finger protein 331) in Gastric Cancer | Dr SUNG Joseph JY |
| 2008.404 | Comparing Acceptance and Yield of Colonoscopy Versus Fecal Immunochemical Test (FIT) in the Detection of Advanced Colonic Neoplasm in Asia (CFA Study) | Prof. SUNG Joseph JY |
| 2010.165 | Functional Significance and Gene Modulation of a Novel Tumor Suppressor T-box 5 in Colon Cancer | Professor SUNG JOSEPH JY |
| 2010.362 | Effectiveness of fall alarm pad in fall prevention for the at risk group of the Chinese elderly in acute hospital of Hong Kong | MR. SUNG Man Ho, Charles |
| 2025.185 | WhatsApp-assisted prehabilitation programme for patient undergoing elective colorectal cancer surgery | MISS SUNG SHERING HOI LING |
| 2024.280 | Improving Accuracy of Genomic Variation Calling in the Hong Kong Population | Prof. Sung Wing Kin |
| 2008.028 | Genetic Determination of Susceptibility to Kawasaki Disease: A Study of Genomic DNA Recovered from Saliva Samples | Professor Sung Yn Tz, Rita |
| 2021.144 | Evaluation of Lift and Place Test with Pain and Disability Scales among Healthy Adults with Non-specific Low Back Pain | Mr. SUTANTO Dhananjaya |
| 2022.176 | Change in chronic low back pain participant trunk and lower limb kinematics after structural exercise program | Mr. SUTANTO Dhananjaya |
| 2025.077 | Abdominal Self-Massage for Elderly with Functional Constipation – A Quasi-Experimental Study |
Mr. SZE Kai Chun 施佳俊 |
| 2022.073 | Diagnostic accuracy of using capnography in verification of nasogastric tube placement in hospital settings | Ms. SZE Savina Yee Man |
| 2022.528 | Retrospective review of COVID-19 Older Patients in the community treatment facility at AsiaWorld-Expo - Geriatric Syndromes, Discharge Planning and Outcomes |
Ms. SZE Savina Yee Man 史綺雯 |
| 2015.561 | Prognostic factors of paediatrics traumatic brain injuries. A review of case series with neurosurgical intervention in a tertiary trauma center from 2003 to 2013. | Dr. SZE Wang Pui |
| 2024.097 | The impact of sign-phonological awareness training on language and literacy development in deaf and hearing bimodal bilingual children | Prof. SZE Yim Binh Felix |
| 2010.410 | Week 24 response and long-term outcomes of lamivudine in patients with chronic hepatitis B - A prospective cohort study | Dr. SZE YUEN CHUN |
| 2011.256 | Prospective study on lcinical predictive value of hepatitis B surface antigen for sustained virologic response to pegylated interferon in patients infected with chronic hepatitis B | Dr. SZE YUEN CHUN |
| 2021.307 | A Phase IIa, Open-Label, 2-Arm Multicenter Clinical Trial to Evaluate the Efficacy, Safety and PK/PD of the Human Anti-CD38 Antibody MOR202 in Anti-PLA2R Antibody Positive Membranous Nephropathy (NewPLACE) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.551 | Mechanisms of Podocyte Protection by Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Kidney Disease |
Prof. SZETO Cheuk Cheuk Chun Szeto |
| 2024.178 | The Efficacy and Safety of Intermittent Sodium Zirconium Cyclosilicate Therapy for the Prevention of Hyperkalemia in Chronic Kidney Disease |
Prof. SZETO Cheuk Chun Szeto Cheuk Chun |
| 2025.136 | Acute kidney injury in acute coronary syndrome: prevalence, risk factors, and prognosis |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.429 | A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) | Prof. SZETO Cheuk Chun |
| 2024.315 | Discontinuation of sodium-glucose cotransporter-2 inhibitors in advanced chronic kidney disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.321 | Defining the optimal frequency of dialysis adequacy test for peritoneal dialysis patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.402 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.381 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2025.310 | Systemic absorption of oral vancomycin: prevalence, risk factors, and clinical implications |
Prof. SZETO Cheuk Chun Cheuk Chun Szeto |
| 2024.609 | Systemic Absorption of Oral Vancomycin Used for the Treatment of Clostridioides Difficile-Associated Diarrhea |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2021.367 | The Prognostic Role of Volume Overload in New Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2021.740 | Fluid Overload as the Cause of Gut Permeability Barrier Dysfunction in Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2022.159 | Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2021.738 | Randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral BI 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chronic kidney disease |
Prof. SZETO Cheuk Chun 司徒卓俊教授 |
| 2023.562 | Urinary Biomarkers for the Early Diagnosis and Prognostic Indicators of Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2023.247 | A multicentered, single-group Phase 2, exploratory, open-label study to investigate safety and effect of sparsentan in combination with sodium glucose cotransporter-2 (SGLT2) inhibition in the treatment of adult participants with Immunoglobulin A nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2023.363 | Modified Creatinine Index as a Non-Invasive Tool for the Monitoring of Muscle Mass in Peritoneal Dialysis |
Prof. SZETO Cheuk Chun Szeto Cheuk Chun |
Page 199 of 265.